Non-inferiority study assessing the utility of postcervical and lumbar radiofrequency ablation steroid use
Regional Anesthesia & Pain Medicine · 2025
DOI: 10.1136/rapm-2024-105501 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Regional Anesthesia & Pain Medicine, 2025. Verfasst von Mark R Williams und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Perioperative Medicine, University of Rochester Medical Center, Rochester, New York, USA mark1_williams@urmc.rochest…. Hauptthemen laut MEDLINE: Radiofrequency Ablation, Postoperative Pain, Lumbar Vertebrae, Cervical Vertebrae. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: National Institutes of Health.
Abstract (Originalsprache)
Introduction
Many physicians administer steroids after radiofrequency ablation (RFA) to mitigate postprocedural inflammation and decrease postprocedural pain. However, robust evidence supporting the benefits of steroids after RFA is lacking and steroids have risks.
Methods
This study was a single-center, prospective, observational study designed to assess whether RFA alone is inferior to RFA with steroids for postprocedure pain. Eligible patients were at least 18 years of age and scheduled to undergo cervical or lumbar RFA. The primary outcome measure was the average pain score on the numeric rating scale (NRS) 7 days after the RFA. The secondary outcome measures included anxiety, depression and physical function, measured via the Patient-Reported Outcomes Measurement Information System short forms. All outcome measures were completed prior to the procedure and at 7 and 60 days postprocedure.
Results
Out of the 365 participants who completed baseline assessments, 175 received steroids and 190 did not receive steroids. The pain intensity at 7 days postprocedure was similar between the steroid and non-steroid groups (mean difference (steroid−non-steroid): −0.23). The 95% CI of the estimate (−0.76 to 0.30) was within the prespecified non-inferiority margin of 1.5 NRS points. Similar results were obtained for pain at 60 days (mean difference: 0.09; 95% CI −0.48 to 0.65). No significant differences between groups were observed for anxiety, depression or physical function at either 7 or 60 days.
Conclusion
This study suggests that the addition of steroids to the RFA procedure does not provide added benefits and is therefore not worth the additional risks that they pose.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology and Perioperative Medicine, University of Rochester Medical Center, Rochester, New York, USA mark1_williams@urmc.rochester.edu.
- Department of Anesthesiology and Perioperative Medicine, University of Rochester Medical Center, Rochester, New York, USA.
- Department of Pain Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
- Department of Biostatistics and Computational Biology, University of Rochester, Rochester, New York, USA.
ORCID-Profile: Mark R Williams
Förderung
- National Institutes of Health
Zitieren
APA
Williams, M. R., Philip, A., Sheen, S., Aujla, S., Feng, C., Gao, S., Kralovic, S., Poli, J., Ortiz, T., Stefanos, T., Pennella-Vaughan, J., & Gewandter, J. S. (2025). Non-inferiority study assessing the utility of postcervical and lumbar radiofrequency ablation steroid use. Regional Anesthesia & Pain Medicine. https://doi.org/10.1136/rapm-2024-105501
Vancouver
Williams MR, Philip A, Sheen S, Aujla S, Feng C, Gao S, et al. Non-inferiority study assessing the utility of postcervical and lumbar radiofrequency ablation steroid use. Regional Anesthesia & Pain Medicine. 2025. doi:10.1136/rapm-2024-105501
BibTeX
@article{Williams2025,
author = {Williams, Mark R and Philip, Annie and Sheen, Soun and Aujla, Saumya and Feng, Changyong and Gao, Shan and Kralovic, Sarah and Poli, Joseph and Ortiz, Tammy and Stefanos, Tatsiana and Pennella-Vaughan, Janet and Gewandter, Jennifer S},
title = {Non-inferiority study assessing the utility of postcervical and lumbar radiofrequency ablation steroid use},
journal = {Regional Anesthesia & Pain Medicine},
year = {2025},
doi = {10.1136/rapm-2024-105501}
}
EUVIMED